News for '-v-2'

Expert warns of more virulent coronavirus after milder Omicron

Expert warns of more virulent coronavirus after milder Omicron

Rediff.com7 Jan 2022

The reduced severity of Omicron is good news for now, but it is the result of an "evolutionary mistake" as Covid-19 is transmitting very efficiently and there is no reason for it to become milder, indicating that the next variant could be more virulent, a leading Indian-origin scientist from the University of Cambridge has warned.

ICMR approves TB machines for COVID-19 testing

ICMR approves TB machines for COVID-19 testing

Rediff.com10 Apr 2020

The ICMR has validated 'TruenatTM beta CoV test on TruelabTM workstation' and has recommended it as a screening test,the apex health research body said on Friday.

2 cases of Omicron found in Karnataka, says govt

2 cases of Omicron found in Karnataka, says govt

Rediff.com2 Dec 2021

Two cases of the new Omicron variant of coronavirus have been detected in Karnataka, the Union government said on Thursday while asking people not to panic but follow Covid-appropriate behaviour and get vaccinated without delay.

Coronavirus mutations may not make it more infectious: Study

Coronavirus mutations may not make it more infectious: Study

Rediff.com26 May 2020

Coronaviruses, like other RNA viruses, can develop mutations in three different ways: by mistake from copying errors during viral replication, through interactions with other viruses infecting the same cell, or they can be induced by RNA modification systems which are part of host immunity, the researchers explained.

'Dengue outbreak may aggravate COVID-19 crisis'

'Dengue outbreak may aggravate COVID-19 crisis'

Rediff.com10 Jul 2020

The impact of a 'dengue-COVID-19' season would entail two different diagnostic tests and extract a huge toll on patients too, each disease making the other more complicated to deal with and perhaps more fatal.

Long Covid has more than 200 symptoms: Study

Long Covid has more than 200 symptoms: Study

Rediff.com15 Jul 2021

The most common symptoms were fatigue, post-exertional malaise -- worsening of symptoms after physical or mental exertion -- and cognitive dysfunction, often called brain fog.

Pfizer jab produces less antibodies against Delta variant: Study

Pfizer jab produces less antibodies against Delta variant: Study

Rediff.com4 Jun 2021

The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time, providing additional evidence in support of plans to deliver a booster dose to vulnerable people.

Oxford launches COVID-19 vaccine study on children

Oxford launches COVID-19 vaccine study on children

Rediff.com13 Feb 2021

This new trial, a single-blind, randomised Phase II trial, will enrol 300 volunteers, with up to 240 of these volunteers receiving the ChAdOx1 nCoV-19 vaccine and the remainder a control meningitis vaccine, which has been shown to be safe in children but is expected to produce similar reactions, such as a sore arm.

PM reviews preparations for vaccination against COVID-19

PM reviews preparations for vaccination against COVID-19

Rediff.com30 Jun 2020

The PM directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately.

India-US coalition begin clinical trials for coronavirus

India-US coalition begin clinical trials for coronavirus

Rediff.com17 Mar 2020

The trial began at the Kaiser Permanente Washington Health Research Institute in Seattle as the first participant received the investigational vaccine.

India reports 6 cases of UK coronavirus strain

India reports 6 cases of UK coronavirus strain

Rediff.com29 Dec 2020

All these persons have been kept in single room isolation at designated health care facilities by respective state governments and their close contacts have also been put under quarantine, the ministry said.

Mixing Covishield, Covaxin shows better immunogenicity: ICMR study

Mixing Covishield, Covaxin shows better immunogenicity: ICMR study

Rediff.com8 Aug 2021

The study titled 'Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime' has been uploaded on medRxiv, a preprint server and is yet to be peer reviewed.

Covid like a Test match, not ODI: AIIMS taskforce chief

Covid like a Test match, not ODI: AIIMS taskforce chief

Rediff.com20 May 2021

Chairperson of the COVID Task Force for All India Institute of Medical Sciences, Dr Naveet Wig on Thursday said that the COVID-19 crisis is 'a dynamic situation' and to prevent a third wave of the pandemic, there is a need to keep changing strategies.

Health secy reviews status of passengers from UK

Health secy reviews status of passengers from UK

Rediff.com23 Dec 2020

Union Health Secretary Rajesh Bhushan reviewed the status of passengers coming from the UK to India and found positive in Maharashtra, Karnataka, Telangana, Tamil Nadu, West Bengal, Goa, Punjab, Gujarat and Kerala and their response measures in a meeting held through video conferencing.

Delta variant 'greatest threat' to US Covid response: Dr Fauci

Delta variant 'greatest threat' to US Covid response: Dr Fauci

Rediff.com23 Jun 2021

However, the "good news" is that the US vaccines are effective against the Delta variant, said Fauci, the head of the National Institutes of Allergy and Infectious Diseases.

Focus on double vaccination first: Experts amid calls for booster

Focus on double vaccination first: Experts amid calls for booster

Rediff.com4 Dec 2021

'Scientific data has proven that masks can reduce COVID-91 transmission by 53 per cent...A booster dose of vaccine, even if it works, is just a temporary fix'

New smartphone-based COVID test gives results in less than 30 minutes

New smartphone-based COVID test gives results in less than 30 minutes

Rediff.com7 Dec 2020

The research found that the device accurately detected a set of positive samples in under 5 minutes.

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Rediff.com19 Jul 2021

So far, no other vaccine has been approved globally for children below 12 years. Sohini Das reports.

'Indian strain' of coronavirus spreads faster: Experts

'Indian strain' of coronavirus spreads faster: Experts

Rediff.com27 Apr 2021

The B.1.617 variant of SARS-CoV2, also being called a 'double mutant' or the 'Indian strain', has been found prevalent largely in Maharashtra and Delhi that have been severely hit by a devastating second wave of the pandemic.

Top medical body favours phased school reopening

Top medical body favours phased school reopening

Rediff.com28 Sep 2021

Evidence indicates that restoration of functioning of the education system as it was in pre-Covid times, as early as possible appears prudent in the current Indian context, they said.

India-UK flights to remain suspended till Jan 7: Puri

India-UK flights to remain suspended till Jan 7: Puri

Rediff.com30 Dec 2020

The civil aviation ministry had last week suspended all flights between the European country and India from December 23 to December 31 as a mutated variant of the coronavirus was detected there.

Is A Vaccine Booster Needed?

Is A Vaccine Booster Needed?

Rediff.com20 Dec 2021

'There is no emergency of a third wave that we are rushing for booster doses.'

Bharat Biotech to make 900 million Covaxin vaccines

Bharat Biotech to make 900 million Covaxin vaccines

Rediff.com1 Jun 2021

500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.

Wastewater containing coronavirus may be potential threat

Wastewater containing coronavirus may be potential threat

Rediff.com25 Aug 2020

According to the scientists, sewage leaking into natural watercourses might lead to infection with the novel coronavirus SARS-CoV-2 via airborne spray.

The Chirping Economist

The Chirping Economist

Rediff.com27 Aug 2021

'These people jump up and down, excitedly waving their arms about to catch the attention of one political party or the other.' 'This mutant can be very dangerous,' observes T C A Srinivasa-Raghavan.

COVID-19 vaccine unlikely before Fall of 2021: Experts

COVID-19 vaccine unlikely before Fall of 2021: Experts

Rediff.com2 Oct 2020

Researchers at McGill University in Canada carried out a survey of 28 experts working in vaccinology in late June 2020. The majority of those surveyed were mostly Canadian or American academics with an average of 25 years of experience working in the field.

Pfizer withheld Covid vaccine news before elections: Trump

Pfizer withheld Covid vaccine news before elections: Trump

Rediff.com10 Nov 2020

Trump had said that he worked on removing a large number of bureaucratic obstacles to fast-track development and approval of a vaccine.

Second round of sero survey begins in Mumbai

Second round of sero survey begins in Mumbai

Rediff.com10 Aug 2020

The study will provide information about the spread of the infection and also throw light on herd immunity.

'Safety, efficacy main concerns with Russia's COVID-19 vaccine'

'Safety, efficacy main concerns with Russia's COVID-19 vaccine'

Rediff.com17 Aug 2020

Nobel laureate Peter Doherty says his 'big worry' is there could be refusals for other vaccines if doubts over its safety turn out to be true.

14-day quarantine, RT-PCR tests: SOPs for passengers from UK

14-day quarantine, RT-PCR tests: SOPs for passengers from UK

Rediff.com2 Jan 2021

Only 30 flights per week will operate between India and the UK when services resume from January 8 and this arrangement will continue till January 23, Aviation Minister Hardeep Singh Puri had said on Friday.

Air pollution may hinder India's fight against COVID-19: Scientists

Air pollution may hinder India's fight against COVID-19: Scientists

Rediff.com27 Oct 2020

Long-term exposure to chronically high PM2.5 levels weakens the ability of the lungs to fend off infections, therefore making people more susceptible to COVID-19, the scientists said.

ICMR plans to scale-up testing capacity to 1 lakh/day

ICMR plans to scale-up testing capacity to 1 lakh/day

Rediff.com6 Apr 2020

The ICMR has approved over 200 labs (both public and private) for COVID-19 testing through-PCR machines.

Coronavirus can last on face masks for a week: Study

Coronavirus can last on face masks for a week: Study

Rediff.com6 Apr 2020

'If you want to protect yourself just maintain good hygiene, wash your hands often and try not to touch your face, your mouth or nose without cleaning first'

Covid: Big 3rd wave unlikely in India, say experts

Covid: Big 3rd wave unlikely in India, say experts

Rediff.com23 Nov 2021

Is the worst of the Covid crisis behind India? As cases dip three weeks after Diwali, the answer is a possible yes, say several experts, attributing the downslide to a large section of the population already exposed to the virus during the second wave and a stepped up vaccination campaign.

Covid patients' symptoms persist for a year: Lancet study

Covid patients' symptoms persist for a year: Lancet study

Rediff.com27 Aug 2021

The research on 1,276 patients from Wuhan, China, shows that around one in three people still experienced shortness of breath after 12 months, while lung impairments persisted in some patients, especially those who had experienced the most severe illness with Covid-19.

Lioness in Tamil Nadu zoo dies of coronavirus, 9 others infected

Lioness in Tamil Nadu zoo dies of coronavirus, 9 others infected

Rediff.com4 Jun 2021

For the first time in Tamil Nadu, a lion has died of coronavirus while nine others in the pride have tested positive for the infection at a zoo near Chennai, an official said.

Phase II trial finds Chinese COVID-19 vaccine is safe

Phase II trial finds Chinese COVID-19 vaccine is safe

Rediff.com21 Jul 2020

Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.

Only 1 Covid strain found in India of concern: WHO

Only 1 Covid strain found in India of concern: WHO

Rediff.com2 Jun 2021

The B.1.617 variant was first detected in India and was divided in three lineages -- B.1.617.1, B.1.617.2 and B.1.617.3.

Covid survives longer on glass, plastic than on cloth, paper: IIT Bombay study

Covid survives longer on glass, plastic than on cloth, paper: IIT Bombay study

Rediff.com15 Feb 2021

A study by researchers from the Indian Institute of Technology Bombay found that a droplet remains liquid for a much shorter time on a porous surface, making it less favourable to the survival of the virus.

New Covid variant: Scientists warn against more mutations

New Covid variant: Scientists warn against more mutations

Rediff.com22 Dec 2020

Over time, as more mutations occur, the vaccine may need to be altered.